Prof. Weixin Zhao 赵伟新
Chief Physician, Professor
Department of Radiation Oncology, Fudan University Shanghai Cancer Center, Shanghai
Public profile Compiled from public listings and PubMed. We do not work directly with this doctor, but we can find a specialist in this field to review your case.
Get a specialist opinionClinical focus: Radiotherapy, chemotherapy, targeted therapy, immunotherapy, and comprehensive treatment for lung cancer, esophageal cancer, cardia cancer, and mediastinal tumors.
Dr. Zhao graduated from Shanghai Medical University in 1999 and earned a master’s in tumor radiotherapy from Fudan University in 2010. Since 1999, Dr. Zhao has worked in the Radiotherapy Department of Fudan University Shanghai Cancer Center, progressing to Chief Physician. Clinical and research focus includes radiotherapy combined with targeted and immunotherapies, particularly for lung, esophageal, and mediastinal tumors. Dr. Zhao has published eight first-author SCI papers and received two provincial-level research grants.
Name order: in Chinese the family name comes first (Zhao Weixin). Papers usually list the name as Weixin Zhao or Zhao W.
Selected publications
39 papers on PubMed matched by name and affiliation; 6 as first or senior author since 2016. Most recent first- or senior-author papers:
- Transl Oncol, 2026 (senior author): Transmembrane glycoprotein BSG serves a dual role as a prognostic and immunological modulator in the tumor microenvironment of lung adenocarcinoma. PubMed 42710246
- BMC Med, 2023 (first author): Rare mutation-dominant compound EGFR-positive NSCLC is associated with enriched kinase domain-resided variants of uncertain significance and poor clinical outcomes. PubMed 36829178
- Front Oncol, 2023 (senior author): Immunotherapy progress and clinical strategy of unresectable locally advanced non-small cell lung cancer. PubMed 36845690
- World J Clin Cases, 2022 (senior author): Principle and progress of radical treatment for locally advanced esophageal squamous cell carcinoma. PubMed 36569017
- Cancer Invest, 2020 (senior author): Co-Expression Network Analysis Identified Genes Associated with Cancer Stem Cell Characteristics in Lung Squamous Cell Carcinoma. PubMed 31770041
- Biochem Biophys Res Commun, 2019 (senior author): Up-regulation of long noncoding RNA MINCR promotes non-small cell of lung cancer growth by negatively regulating miR-126/SLC7A5 axis. PubMed 30528230
- Tumour Biol, 2013 (first author): Serum neuron-specific enolase levels were associated with the prognosis of small cell lung cancer: a meta-analysis. PubMed 23775010
- Tumour Biol, 2013 (first author): Association between microsomal epoxide hydrolase 1 polymorphisms and susceptibility to esophageal cancer: a meta-analysis. PubMed 23681797
See the full PubMed search. Automatic matching can miss papers or include a namesake at the same hospital.
This profile has not been reviewed by the doctor. How we build this directory.
Want a specialist to review your case?
Send your records. We find a specialist in this field who can review your case and write a treatment plan with a cost estimate.
Get a specialist opinion